FIREBRICK PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.053 AUD | -5.36% |
|
-7.02% | +6.00% |
| 06-13 | Firebrick Pharma Launches Nasodine Nasal Spray in Singapore | MT |
| 05-23 | Firebrick Pharma Obtains Nasodine Composition Patent in South Africa | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FIREBRICK PHARMA LIMITED | Other Pharmaceuticals | -5.36% | -7.02% | +6.00% | -65.81% | - | 7.3M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- FRE Stock
- Charts Firebrick Pharma Limited
- Comparison Chart
